BRINAVESS
Google image searchProduct monograph
Active ingredient
vernakalant hydrochloride, 20 MG/ML
DIN: 02462400
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: CIPHER PHARMACEUTICALS INC
Date: 15-JUL-2020
ATC:
- C01 — CARDIAC THERAPY (ATC, ATC/DDD, )
- C01B — ANTIARRHYTHMICS, CLASS I AND III (ATC, ATC/DDD)
- C01BG — Other antiarrhythmics, class I and III (ATC, ATC/DDD)
- C01BG11 — VERNAKALANT (ATC/DDD)
Reference brand drug: Brinavess
